Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
AksharChem (India) Limited (524598) fair value: what the stock is really worth
We calculate from audited financials what AksharChem (India) Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
- Fair value above price? No
- Good quality? Yes
- Add to watchlist
AI
Some data
Sep 13, 2026
AksharChem (India) Limited
524598 · BSEStretched ValuationStrong overvaluation with only moderate quality.
!Fair value ₹98.87 · Strongly overvalued (−76%)
!Quality 62/100
!Weak Growth (revenue 5y +5.9 %/yr)
!Thin margins · 5.0% net margin (TTM)
✓Low debt
·1.68% dividend yield
!Narrow moat 42/100
!Evidence only medium, so the estimate is less certain
Watch AksharChem (India) Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.
Watch for free
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
60‑month range ₹144.90 – ₹558.56 · fair‑value band ₹74.15 – ₹100.18 · the ₹416.90 price screens above the ₹98.87 fair value. Dashed = 300-day average. As of Sep 13, 2026.
Company profile
AksharChem (India) Limited engages in the manufacture and sale of dyes and pigments in India. The company offers vinyl sulphone, sulpho para vinyl sulphone, ortho anicidine vinyl sulphone, and h-acid for use in the textile industry; and CPC green for printing ink, rubber, plastic, paint, and leather industries.
Show more
AksharChem (India) Limited engages in the manufacture and sale of dyes and pigments in India. The company offers vinyl sulphone, sulpho para vinyl sulphone, ortho anicidine vinyl sulphone, and h-acid for use in the textile industry; and CPC green for printing ink, rubber, plastic, paint, and leather industries. It also exports its products to Europe, the Far East, South East Asia, China, the United States, and internationally. The company was formerly known as Audichem (India) Limited and changed its name to AksharChem (India) Limited in March 2003. AksharChem (India) Limited was founded in 1989 and is headquartered in Mehsana, India.
Stock analysis
AksharChem (India) Limited (524598) currently trades at ₹416.90, while our model-based Fair Value estimate is ₹98.87, implying the stock looks roughly 321.6% overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ₹215.40 per share, and 0 of the 14 models we run sit above the ₹416.90 price.
Bear case: the Earnings-Based group reads lowest at ₹66.46, and 14 of the 14 models stay below the price. Evidence for this calculation is medium.
Scenario range: ₹74.15 (bear) to ₹100.18 (bull), the price of ₹416.90 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
AksharChem (India) Limited reported revenue of ₹3.5B in FY2025 versus ₹2.5B in FY2021, a compound +8.9%/yr. Reported net income was ₹47.7M in FY2025, compounding −21.4%/yr from FY2021.
Key figures
Market cap ₹1.7B (≈ $17.6M) · P/E ratio 14.0 · P/S ratio 0.19 · EPS (TTM) ₹19.17 · Dividend yield 1.7% · Net margin 1.4% · Return on equity 4.4% · Return on assets (EBIT) 1.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (medium confidence).
What moves the price
The share trades near its 52-week high and 192% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −47% fair-value upside, at −76%, 524598 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (₹4.94 to ₹286.70). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ₹74.15
Fair Value ₹98.87
Bull ₹100.18
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then (₹12.17 per share) are deliberately not added.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Residual Income
₹210.15
₹191.43
₹135.42
76
EPV
₹56.56
₹66.46
₹74.71
74
ROIC Compounder
₹56.56
₹66.46
₹74.71
72
All 14 models by family
Earnings-Based
Graham-Dodd
₹39.55
₹76.88
₹96.13
66
EPV
₹56.56
₹66.46
₹74.71
74
Dividend Discount
Gordon GGM
₹3.74
₹4.94
₹6.04
69
DDM Multi-Stage
₹3.74
₹4.94
₹6.17
67
Multiples
P/E Multiple
₹74.15
₹98.87
₹123.58
63
P/S Multiple
₹74.15
₹98.87
₹123.58
58
P/B Multiple
₹74.15
₹98.87
₹123.58
55
EV/EBIT
₹122.60
₹168.82
₹215.04
66
EV/EBITDA
₹211.01
₹286.70
₹362.39
67
EV/Revenue
₹104.12
₹155.62
₹207.12
53
Asset-Based
NCAV (Graham)
₹160.75
₹215.40
₹321.50
54
Economic Profit
Residual Income
₹210.15
₹191.43
₹135.42
76
ROIC Compounder
₹56.56
₹66.46
₹74.71
72
Growth Earnings
Growth-Adj P/E
₹53.94
₹77.06
₹100.18
67
Notify me when 524598 reaches fair value
Put 524598 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
62/100
Of which business quality 59 · Market factors (momentum, volatility) 71
Profitability
37
Margins and returns on capital today
Quality Growth
78
Are margins and returns improving?
Cashflow
48
Earnings quality: real cash, not paper profit
Fin. Strength
52
Balance sheet, leverage, solvency risk
Investment
79
Disciplined investing over empire-building
Low Volatility
28
Calm price path (market factor)
Momentum
83
Price trend over the last 3–12 months (market factor)
52W Momentum
99
Distance to the 52-week high (market factor)
Net Issuance
82
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
39/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+14.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−19.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−20.9%
Dividend (yield on the price)1.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 3%
524598 screens 322% overvalued. Compare with Linde plc →
Compare AksharChem (India) Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Other · 128 stocks
Beats the industry median on 10/13 measures
Overall it ranks above its industry peers.
Valuation Multiplesvs Other median · lower = cheaper
Context: sector, industry, market
- Is the Materials sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $466.22 | $425.24 | −9% |
| The Sherwin-Williams Company SHW | $323.31 | $143.38 | −56% |
| Ecolab Inc ECL | $276.18 | $96.18 | −65% |
| Air Products and Chemicals, Inc APD | $291.43 | $122.14 | −58% |
| Nan Ya Plastics Corporation 1303 | 234.50 TWD | 306.47 TWD | +31% |
| Givaudan SA GIVN | CHF 3,164 | CHF 1,523 | −52% |
| Wanhua Chemical Group 600309 | ¥74.50 | ¥68.03 | −9% |
| 500820 500820 | ₹2,470 | ₹393.15 | −84% |
| Sika AG SIKA | CHF 185.00 | CHF 98.89 | −47% |
| Novozymes A/S NSISB | kr 427.30 | kr 383.60 | −10% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is AksharChem (India) Limited (524598) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of ₹98.87 versus a price of ₹416.90, about −76% upside (overvalued).
What is the fair value of 524598?
Our model-based fair value for AksharChem (India) Limited is ₹98.87 (as of Sep 13, 2026), built from audited fundamentals. The current price: ₹416.90.
What is the quality score of 524598?
AksharChem (India) Limited has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for AksharChem (India) Limited (524598)?
Our model-based price target is the fair value of ₹98.87 (as of Sep 13, 2026) from 14 valuation models. Cautious scenario ₹74.15, optimistic scenario ₹100.18. It is a calculation from audited fundamentals, not an analyst target.
What is the AksharChem (India) Limited stock forecast for 2026?
Our models put fair value at ₹98.87, about −76% upside versus a price of ₹416.90 (overvalued). Cautious scenario ₹74.15, optimistic scenario ₹100.18. The calculation is refreshed regularly with new filings.
What is the revenue of AksharChem (India) Limited (524598)?
AksharChem (India) Limited reported trailing-twelve-month revenue of about ₹2.3B (latest available figure, as of Sep 13, 2026).
Does AksharChem (India) Limited pay a dividend?
AksharChem (India) Limited currently shows a dividend yield of about 1.68% relative to its recent price (as of Sep 13, 2026).
What is the intrinsic value of AksharChem (India) Limited (524598)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For AksharChem (India) Limited it is ₹98.87 per share (as of Sep 13, 2026), against a price of ₹416.90. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is AksharChem (India) Limited stock overvalued or undervalued in 2026?
As of Sep 13, 2026, 524598 trades above its calculated fair value: price ₹416.90, fair value ₹98.87, a gap of about −76% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 524598?
No. The price is what the market pays today (₹416.90); the fair value is what the company's own numbers justify (₹98.87). For AksharChem (India) Limited the two are ₹318.03 per share apart. That gap is exactly why we show both numbers side by side.
How much is AksharChem (India) Limited worth?
The market values AksharChem (India) Limited at about ₹1.7B (market capitalisation, as of Sep 13, 2026). Per share that is ₹416.90; our models calculate a fair value of ₹98.87 per share.
What do the bullish and bearish scenarios say about 524598?
Our models span a range for AksharChem (India) Limited: cautious scenario ₹74.15, base ₹98.87, optimistic ₹100.18 per share (as of Sep 13, 2026, price ₹416.90). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 524598?
AksharChem (India) Limited trades at a price-to-earnings ratio of 14.0 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹98.87 is built from several models across several years. Other multiples: P/B 0.6, P/S 0.7, EV/EBITDA 7.6.
How solid is the balance sheet of AksharChem (India) Limited (524598)?
Balance-sheet figures for AksharChem (India) Limited (as of Sep 13, 2026): return on equity 4.4%, debt of 0.05 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is 524598 from its 52-week high?
AksharChem (India) Limited trades at ₹416.90, about 26% below its 52-week high of ₹329.89 and 192% above the low of ₹142.90 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of ₹98.87 is for.
Which stocks are comparable to AksharChem (India) Limited?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is AksharChem (India) Limited stock attractive at the current price?
The data as of Sep 13, 2026: price ₹416.90, calculated fair value ₹98.87 (−76%), Quality Score 62/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 524598 calculated?
We run AksharChem (India) Limited through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹98.87, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. AksharChem (India) Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with AksharChem (India) Limited right now?
The price sits above even our optimistic bull case (₹100.18). The favourable scenario is already priced in. Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of AksharChem (India) Limited
How large is the market capitalisation of AksharChem (India) Limited (524598)?
The market capitalisation of AksharChem (India) Limited is ₹1.7B (≈ $17.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of AksharChem (India) Limited (524598)?
The price-to-sales ratio of AksharChem (India) Limited is 0.19 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of AksharChem (India) Limited (524598)?
Earnings per share at AksharChem (India) Limited are ₹19.17 (price ÷ EPS = P/E 14.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of AksharChem (India) Limited (524598)?
The dividend yield of AksharChem (India) Limited is 1.7% (payout 36.5%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of AksharChem (India) Limited (524598)?
The net margin of AksharChem (India) Limited is 1.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of AksharChem (India) Limited (524598)?
The return on equity (ROE) of AksharChem (India) Limited is 4.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of AksharChem (India) Limited (524598)?
On an EBIT basis the return on assets of AksharChem (India) Limited is 1.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of AksharChem (India) Limited (524598)?
The operating margin of AksharChem (India) Limited is 7.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at AksharChem (India) Limited (524598)?
Revenue at AksharChem (India) Limited is growing −22.2% versus a year earlier (3y avg −3.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at AksharChem (India) Limited (524598)?
Earnings per share at AksharChem (India) Limited are growing −62.3% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch AksharChem (India) Limited in the live analysis
One click puts AksharChem (India) Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.